Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	Oliena Studio Stroke and language recovery: 9000+ videos Español • Italiano • Sardu • English | PDF+

Colorectal Neoplasms

Free Subscription Articles published in Int J Oncol Retrieve available abstracts of 74 articles: HTML format Text format

Single Articles

June 2019
1. PARK YL, Kim SH, Park SY, Jung MW, et al
   Forkheadbox A1 regulates tumor cell growth and predicts prognosis in colorectal cancer.
   Int J Oncol. 2019;54:2169-2178.
   PubMed     Text format     Abstract available
   
   
   March 2019
2. CAI Z, Wang L, Han Y, Gao W, et al
   Immunoglobulinlike transcript 4 and human leukocyte antigenG interaction promotes the progression of human colorectal cancer.
   Int J Oncol. 2019 Mar 22. doi: 10.3892/ijo.2019.4761.
   PubMed     Text format     Abstract available
   
   
   
3. SUN J, Feng Y, Wang Y, Ji Q, et al
   alpha-hederin induces autophagic cell death in colorectal cancer cells through reactive oxygen species dependent AMPK/mTOR signaling pathway activation.
   Int J Oncol. 2019 Mar 19. doi: 10.3892/ijo.2019.4757.
   PubMed     Text format     Abstract available
   
   
   
4. KIM SL, Min IS, Park YR, Lee ST, et al
   [Corrigendum] Lipocalin 2 inversely regulates TRAIL sensitivity through p38 MAPKmediated DR5 regulation in colorectal cancer.
   Int J Oncol. 2019 Mar 13. doi: 10.3892/ijo.2019.4748.
   PubMed     Text format     Abstract available
   
   
   
5. PARK YL, Ha SY, Park SY, Choi JH, et al
   Reversine induces cell cycle arrest and apoptosis via upregulation of the Fas and DR5 signaling pathways in human colorectal cancer cells.
   Int J Oncol. 2019 Mar 13. doi: 10.3892/ijo.2019.4746.
   PubMed     Text format     Abstract available
   
   
   February 2019
6. BAO Y, Lu Y, Feng W, Yu H, et al
   COUPTFII promotes epithelialmesenchymal transition by inhibiting miR34a expression in colorectal cancer.
   Int J Oncol. 2019 Feb 18. doi: 10.3892/ijo.2019.4718.
   PubMed     Text format     Abstract available
   
   
   
7. LIAO Z, Zhang H, Fan P, Huang Q, et al
   High PLK4 expression promotes tumor progression and induces epithelialmesenchymal transition by regulating the Wnt/betacatenin signaling pathway in colorectal cancer.
   Int J Oncol. 2019;54:479-490.
   PubMed     Text format     Abstract available
   
   
   
8. CHIBAUDEL B, Bachet JB, Andre T, Auby D, et al
   Efficacy of aflibercept with FOLFOX and maintenance with fluoropyrimidine as firstline therapy for metastatic colorectal cancer: GERCOR VELVET phase II study.
   Int J Oncol. 2019 Feb 1. doi: 10.3892/ijo.2019.4709.
   PubMed     Text format     Abstract available
   
   
   January 2019
9. YAMAGUCHI M, Hankinson O
   2,3,7,8tetrachlorodibenzopdioxin suppresses the growth of human colorectal cancer cells in vitro: Implication of the aryl hydrocarbon receptor signaling.
   Int J Oncol. 2019 Jan 30. doi: 10.3892/ijo.2019.4703.
   PubMed     Text format     Abstract available
   
   
   
10. TANG L, Zhao P, Kong D
    Muscleblindlike 1 destabilizes Snail mRNA and suppresses the metastasis of colorectal cancer cells via the Snail/Ecadherin axis.
    Int J Oncol. 2019 Jan 18. doi: 10.3892/ijo.2019.4691.
    PubMed     Text format     Abstract available
    
    
    
11. ZHAO H, Yan C, Hu Y, Mu L, et al
    Sphereforming assay vs. organoid culture: Determining longterm stemness and the chemoresistant capacity of primary colorectal cancer cells.
    Int J Oncol. 2019 Jan 11. doi: 10.3892/ijo.2019.4683.
    PubMed     Text format     Abstract available
    
    
    
12. HOKONOHARA K, Nishida N, Miyoshi N, Takahashi H, et al
    Involvement of MAF1 homolog, negative regulator of RNA polymerase III in colorectal cancer progression.
    Int J Oncol. 2019 Jan 7. doi: 10.3892/ijo.2019.4678.
    PubMed     Text format     Abstract available
    
    
    December 2018
13. CHENG Y, Lu Y, Zhang D, Lian S, et al
    Metastatic cancer cells compensate for low energy supplies in hostile microenvironments with bioenergetic adaptation and metabolic reprogramming.
    Int J Oncol. 2018;53:2590-2604.
    PubMed     Text format     Abstract available
    
    
    November 2018
14. LE DT, Jung S, Quynh NTN, Sandag Z, et al
    Inhibitory role of AMPactivated protein kinase in necroptosis of HCT116 colon cancer cells with p53 null mutation under nutrient starvation.
    Int J Oncol. 2018 Nov 14. doi: 10.3892/ijo.2018.4634.
    PubMed     Text format     Abstract available
    
    
    
15. WANG ZZ, Yang J, Jiang BH, Di JB, et al
    KIF14 promotes cell proliferation via activation of Akt and is directly targeted by miR-200c in colorectal cancer.
    Int J Oncol. 2018;53:1939-1952.
    PubMed     Text format     Abstract available
    
    
    
16. QIAN W, Zhang Z, Peng W, Li J, et al
    CDCA3 mediates p21-dependent proliferation by regulating E2F1 expression in colorectal cancer.
    Int J Oncol. 2018;53:2021-2033.
    PubMed     Text format     Abstract available
    
    
    
17. LEI X, Deng L, Liu D, Liao S, et al
    ARHGEF7 promotes metastasis of colorectal adenocarcinoma by regulating the motility of cancer cells.
    Int J Oncol. 2018;53:1980-1996.
    PubMed     Text format     Abstract available
    
    
    October 2018
18. LIU SQ, Xu CY, Wu WH, Fu ZH, et al
    Sphingosine kinase 1 promotes the metastasis of colorectal cancer by inducing the epithelialmesenchymal transition mediated by the FAK/AKT/MMPs axis.
    Int J Oncol. 2018 Oct 25. doi: 10.3892/ijo.2018.4607.
    PubMed     Text format     Abstract available
    
    
    
19. LIU L, Liu H, Zhou Y, He J, et al
    HLTF suppresses the migration and invasion of colorectal cancer cells via TGFbeta/SMAD signaling in vitro.
    Int J Oncol. 2018 Oct 10. doi: 10.3892/ijo.2018.4591.
    PubMed     Text format     Abstract available
    
    
    
20. WANG Y, Yang L, Zhang J, Zhou M, et al
    Radiosensitization by irinotecan is attributed to G2/M phase arrest, followed by enhanced apoptosis, probably through the ATM/Chk/Cdc25C/Cdc2 pathway in p53-mutant colorectal cancer cells.
    Int J Oncol. 2018;53:1667-1680.
    PubMed     Text format     Abstract available
    
    
    
21. PAREDES J, Ji P, Lacomb JF, Shroyer KR, et al
    Establishment of three novel cell lines derived from African American patients with colorectal carcinoma: A unique tool for assessing racial health disparity.
    Int J Oncol. 2018;53:1516-1528.
    PubMed     Text format     Abstract available
    
    
    
22. SCHROTEROVA L, Jezkova A, Rudolf E, Caltova K, et al
    Inositol hexaphosphate limits the migration and the invasiveness of colorectal carcinoma cells in vitro.
    Int J Oncol. 2018;53:1625-1632.
    PubMed     Text format     Abstract available
    
    
    September 2018
23. TURANO M, Costabile V, Cerasuolo A, Duraturo F, et al
    Characterisation of mesenchymal colon tumour-derived cells in tumourspheres as a model for colorectal cancer progression.
    Int J Oncol. 2018 Sep 18. doi: 10.3892/ijo.2018.4565.
    PubMed     Text format     Abstract available
    
    
    
24. KIM SL, Min IS, Park YR, Lee ST, et al
    Lipocalin 2 inversely regulates TRAIL sensitivity through p38 MAPK-mediated DR5 regulation in colorectal cancer.
    Int J Oncol. 2018 Sep 14. doi: 10.3892/ijo.2018.4562.
    PubMed     Text format     Abstract available
    
    
    August 2018
25. ZHANG Z, Fang C, Wang Y, Zhang J, et al
    COL1A1: A potential therapeutic target for colorectal cancer expressing wild-type or mutant KRAS.
    Int J Oncol. 2018 Aug 22. doi: 10.3892/ijo.2018.4536.
    PubMed     Text format     Abstract available
    
    
    
26. LIU RX, Ma Y, Hu XL, Ren WY, et al
    Anticancer effects of oridonin on colon cancer are mediated via BMP7/p38 MAPK/p53 signaling.
    Int J Oncol. 2018 Aug 16. doi: 10.3892/ijo.2018.4527.
    PubMed     Text format     Abstract available
    
    
    
27. WANG Z, Zhao X, Wang W, Liu Y, et al
    ZBTB7 evokes 5-fluorouracil resistance in colorectal cancer through the NFkappaB signaling pathway.
    Int J Oncol. 2018 Aug 10. doi: 10.3892/ijo.2018.4521.
    PubMed     Text format     Abstract available
    
    
    
28. LUCAS J, Hsieh TC, Halicka HD, Darzynkiewicz Z, et al
    Upregulation of PDL1 expression by resveratrol and piceatannol in breast and colorectal cancer cells occurs via HDAC3/p300mediated NFkappaB signaling.
    Int J Oncol. 2018 Aug 1. doi: 10.3892/ijo.2018.4512.
    PubMed     Text format     Abstract available
    
    
    July 2018
29. ZHOU L, Zhan ML, Tang Y, Xiao M, et al
    Effects of beta-caryophyllene on arginine ADP-ribosyltransferase 1-mediated regulation of glycolysis in colorectal cancer under high-glucose conditions.
    Int J Oncol. 2018 Jul 27. doi: 10.3892/ijo.2018.4506.
    PubMed     Text format     Abstract available
    
    
    
30. KWAK B, Kim DU, Kim TO, Kim HS, et al
    MicroRNA-552 links Wnt signaling to p53 tumor suppressor in colorectal cancer.
    Int J Oncol. 2018 Jul 26. doi: 10.3892/ijo.2018.4505.
    PubMed     Text format     Abstract available
    
    
    
31. HUANG M, Geng Y, Deng Q, Li R, et al
    Translationally controlled tumor protein affects colorectal cancer metastasis through the high mobility group box 1-dependent pathway.
    Int J Oncol. 2018 Jul 25. doi: 10.3892/ijo.2018.4502.
    PubMed     Text format     Abstract available
    
    
    
32. CARRIERE PP, Kapur N, Mir H, Ward AB, et al
    Cinnamtannin B-1 inhibits cell survival molecules and induces apoptosis in colon cancer.
    Int J Oncol. 2018 Jul 19. doi: 10.3892/ijo.2018.4489.
    PubMed     Text format     Abstract available
    
    
    
33. ZHANG H, Yang W, Yan J, Zhou K, et al
    Loss of profilin 2 contributes to enhanced epithelial-mesenchymal transition and metastasis of colorectal cancer.
    Int J Oncol. 2018 Jul 9. doi: 10.3892/ijo.2018.4475.
    PubMed     Text format     Abstract available
    
    
    
34. ZHOU ZP, Wang LP, Hong ZS, Qiu CZ, et al
    Silencing GOLPH3 gene expression reverses resistance to cisplatin in HT29 colon cancer cells via multiple signaling pathways.
    Int J Oncol. 2018 Jul 5. doi: 10.3892/ijo.2018.4471.
    PubMed     Text format     Abstract available
    
    
    
35. LIU M, Zhao G, Zhang D, An W, et al
    Active fraction of clove induces apoptosis via PI3K/Akt/mTOR-mediated autophagy in human colorectal cancer HCT-116 cells.
    Int J Oncol. 2018 Jul 2. doi: 10.3892/ijo.2018.4465.
    PubMed     Text format     Abstract available
    
    
    June 2018
36. SU P, Yang Y, Wang G, Chen X, et al
    Curcumin attenuates resistance to irinotecan via induction of apoptosis of cancer stem cells in chemoresistant colon cancer cells.
    Int J Oncol. 2018 Jun 29. doi: 10.3892/ijo.2018.4461.
    PubMed     Text format     Abstract available
    
    
    
37. YAMAGUCHI M, Osuka S, Murata T
    Prolonged survival of patients with colorectal cancer is associated with a higher regucalcin gene expression: Overexpression of regucalcin suppresses the growth of human colorectal carcinoma cells in vitro.
    Int J Oncol. 2018 Jun 28. doi: 10.3892/ijo.2018.4458.
    PubMed     Text format     Abstract available
    
    
    
38. LEE SR, Jin H, Kim WT, Kim WJ, et al
    Tristetraprolin activation by resveratrol inhibits the proliferation and metastasis of colorectal cancer cells.
    Int J Oncol. 2018 Jun 25. doi: 10.3892/ijo.2018.4453.
    PubMed     Text format     Abstract available
    
    
    
39. CHEN ZP, Wei JC, Wang Q, Yang P, et al
    Long noncoding RNA 00152 functions as a competing endogenous RNA to regulate NRP1 expression by sponging with miRNA206 in colorectal cancer.
    Int J Oncol. 2018 Jun 22. doi: 10.3892/ijo.2018.4451.
    PubMed     Text format     Abstract available
    
    
    
40. WANG B, Yin M, Cheng C, Jiang H, et al
    Decreased expression of miR4903p in colorectal cancer predicts poor prognosis and promotes cell proliferation and invasion by targeting RAB14.
    Int J Oncol. 2018 Jun 19. doi: 10.3892/ijo.2018.4444.
    PubMed     Text format     Abstract available
    
    
    
41. QIAN K, Huang H, Jiang J, Xu D, et al
    Identifying autophagy gene-associated module biomarkers through construction and analysis of an autophagy-mediated ceRNAceRNA interaction network in colorectal cancer.
    Int J Oncol. 2018 Jun 18. doi: 10.3892/ijo.2018.4443.
    PubMed     Text format     Abstract available
    
    
    
42. CHEN J, Gong C, Mao H, Li Z, et al
    E2F1/SP3/STAT6 axis is required for IL-4-induced epithelial-mesenchymal transition of colorectal cancer cells.
    Int J Oncol. 2018 Jun 5. doi: 10.3892/ijo.2018.4429.
    PubMed     Text format     Abstract available
    
    
    
43. MORTENSEN AC, Spiegelberg D, Haylock AK, Lundqvist H, et al
    Preclinical evaluation of a novel engineered recombinant human anti-CD44v6 antibody for potential use in radio-immunotherapy.
    Int J Oncol. 2018;52:1875-1885.
    PubMed     Text format     Abstract available
    
    
    
44. CHOWCHAIKONG N, Nilwarangkoon S, Laphookhieo S, Tanunyutthawongse C, et al
    p38 inhibitor inhibits the apoptosis of cowanin-treated human colorectal adenocarcinoma cells.
    Int J Oncol. 2018;52:2031-2040.
    PubMed     Text format     Abstract available
    
    
    May 2018
45. JIANG J, Liu HL, Tao L, Lin XY, et al
    Let7d inhibits colorectal cancer cell proliferation through the CST1/p65 pathway.
    Int J Oncol. 2018 May 23. doi: 10.3892/ijo.2018.4419.
    PubMed     Text format     Abstract available
    
    
    
46. ZHANG Y, Feng Y, Ji D, Wang Q, et al
    TRIM27 functions as an oncogene by activating epithelial-mesenchymal transition and p-AKT in colorectal cancer.
    Int J Oncol. 2018 May 16. doi: 10.3892/ijo.2018.4408.
    PubMed     Text format     Abstract available
    
    
    
47. LEE DH, Won HR, Ryu HW, Han JM, et al
    The HDAC6 inhibitor ACY1215 enhances the anticancer activity of oxaliplatin in colorectal cancer cells.
    Int J Oncol. 2018 May 11. doi: 10.3892/ijo.2018.4405.
    PubMed     Text format     Abstract available
    
    
    
48. SU MQ, Zhou YR, Rao X, Yang H, et al
    Baicalein induces the apoptosis of HCT116 human colon cancer cells via the upregulation of DEPP/Gadd45a and activation of MAPKs.
    Int J Oncol. 2018 May 11. doi: 10.3892/ijo.2018.4402.
    PubMed     Text format     Abstract available
    
    
    
49. LI X, Zhao X, Yang B, Li Y, et al
    Long non-coding RNA HOXD-AS1 promotes tumor progression and predicts poor prognosis in colorectal cancer.
    Int J Oncol. 2018 May 9. doi: 10.3892/ijo.2018.4400.
    PubMed     Text format     Abstract available
    
    
    April 2018
50. PARK BK, Park JY, Kim TH, Kim D, et al
    Production of an anti-TM4SF5 monoclonal antibody and its application in the detection of TM4SF5 as a possible marker of a poor prognosis in colorectal cancer.
    Int J Oncol. 2018 Apr 26. doi: 10.3892/ijo.2018.4385.
    PubMed     Text format     Abstract available
    
    
    
51. WU S, Wu F, Jiang Z
    Effect of HOXA6 on the proliferation, apoptosis, migration and invasion of colorectal cancer cells.
    Int J Oncol. 2018 Apr 2. doi: 10.3892/ijo.2018.4352.
    PubMed     Text format     Abstract available
    
    
    
52. TOMIDA C, Yamagishi N, Nagano H, Uchida T, et al
    VEGF pathway-targeting drugs induce evasive adaptation by activation of neuropilin-1/cMet in colon cancer cells.
    Int J Oncol. 2018;52:1350-1362.
    PubMed     Text format     Abstract available
    
    
    March 2018
53. XIE Y, Liu Y, Li Q, Chen J, et al
    Polo-like kinase 2 promotes chemoresistance and predicts limited survival benefit from adjuvant chemotherapy in colorectal cancer.
    Int J Oncol. 2018 Mar 20. doi: 10.3892/ijo.2018.4328.
    PubMed     Text format     Abstract available
    
    
    
54. JIN L, Si Y, Hong X, Liu P, et al
    Ethoxysanguinarine inhibits viability and induces apoptosis of colorectal cancer cells by inhibiting CIP2A.
    Int J Oncol. 2018 Mar 16. doi: 10.3892/ijo.2018.4323.
    PubMed     Text format     Abstract available
    
    
    
55. MATSUHASHI N, Takahashi T, Matsui S, Tanahashi T, et al
    A novel therapeutic strategy of personalized medicine based on anti-epidermal growth factor receptor monoclonal antibodies in patients with metastatic colorectal cancer.
    Int J Oncol. 2018 Mar 16. doi: 10.3892/ijo.2018.4322.
    PubMed     Text format     Abstract available
    
    
    
56. MAEDA Y, Takahashi H, Nakai N, Yanagita T, et al
    Apigenin induces apoptosis by suppressing Bcl-xl and Mcl-1 simultaneously via signal transducer and activator of transcription 3 signaling in colon cancer.
    Int J Oncol. 2018 Mar 7. doi: 10.3892/ijo.2018.4308.
    PubMed     Text format     Abstract available
    
    
    
57. SU C, Li D, Li N, Du Y, et al
    Studying the mechanism of PLAGL2 overexpression and its carcinogenic characteristics based on 3'-untranslated region in colorectal cancer.
    Int J Oncol. 2018 Mar 6. doi: 10.3892/ijo.2018.4305.
    PubMed     Text format     Abstract available
    
    
    
58. LI N, Mao D, Cao Y, Li H, et al
    Downregulation of SIRT6 by miR-34c-5p is associated with poor prognosis and promotes colon cancer proliferation through inhibiting apoptosis via the JAK2/STAT3 signaling pathway.
    Int J Oncol. 2018 Mar 5. doi: 10.3892/ijo.2018.4304.
    PubMed     Text format     Abstract available
    
    
    February 2018
59. HE P, Li K, Li SB, Hu TT, et al
    Upregulation of AKAP12 with HDAC3 depletion suppresses the progression and migration of colorectal cancer.
    Int J Oncol. 2018 Feb 23. doi: 10.3892/ijo.2018.4284.
    PubMed     Text format     Abstract available
    
    
    
60. BAI B, Xie B, Pan Z, Shan L, et al
    Identification of candidate genes and long non-coding RNAs associated with the effect of ATP5J in colorectal cancer.
    Int J Oncol. 2018 Feb 22. doi: 10.3892/ijo.2018.4281.
    PubMed     Text format     Abstract available
    
    
    
61. FORSTER S, Hehlgans S, Rodel F, Otto B, et al
    Differential effects of alpha-catenin on the invasion and radiochemosensitivity of human colorectal cancer cells.
    Int J Oncol. 2018 Feb 21. doi: 10.3892/ijo.2018.4279.
    PubMed     Text format     Abstract available
    
    
    
62. NISHIZAWA Y, Konno M, Asai A, Koseki J, et al
    Hypoxia stimulates the cytoplasmic localization of oncogenic long noncoding RNA LINC00152 in colorectal cancer.
    Int J Oncol. 2018;52:453-460.
    PubMed     Text format     Abstract available
    
    
    
63. CHEN J, Lou Q, He L, Wen C, et al
    Reduced-gliotoxin induces ROS-mediated anoikis in human colorectal cancer cells.
    Int J Oncol. 2018 Feb 1. doi: 10.3892/ijo.2018.4264.
    PubMed     Text format     Abstract available
    
    
    January 2018
64. NAGATA H, Ishihara S, Kishikawa J, Sonoda H, et al
    CD133 expression predicts post-operative recurrence in patients with colon cancer with peritoneal metastasis.
    Int J Oncol. 2018 Jan 8. doi: 10.3892/ijo.2018.4240.
    PubMed     Text format     Abstract available
    
    
    
65. LEE JY, Kim MS, Ju JE, Lee MS, et al
    Simvastatin enhances the radiosensitivity of p53deficient cells via inhibition of mouse double minute 2 homolog.
    Int J Oncol. 2018;52:211-218.
    PubMed     Text format     Abstract available
    
    
    November 2017
66. OLEJNICZAK A, Szarynska M, Kmiec Z
    In vitro characterization of spheres derived from colorectal cancer cell lines.
    Int J Oncol. 2017 Nov 16. doi: 10.3892/ijo.2017.4206.
    PubMed     Text format     Abstract available
    
    
    
67. TANG YC, Zhang Y, Zhou J, Zhi Q, et al
    Ginsenoside Rg3 targets cancer stem cells and tumor angiogenesis to inhibit colorectal cancer progression in vivo.
    Int J Oncol. 2017 Nov 1. doi: 10.3892/ijo.2017.4183.
    PubMed     Text format     Abstract available
    
    
    
68. IZDEBSKA M, Gagat M, Grzanka A
    Overexpression of lamin B1 induces mitotic catastrophe in colon cancer LoVo cells and is associated with worse clinical outcomes.
    Int J Oncol. 2017 Nov 1. doi: 10.3892/ijo.2017.4182.
    PubMed     Text format     Abstract available
    
    
    October 2017
69. DACHINENI R, Kumar DR, Callegari E, Kesharwani SS, et al
    Salicylic acid metabolites and derivatives inhibit CDK activity: Novel insights into aspirin's chemopreventive effects against colorectal cancer.
    Int J Oncol. 2017 Oct 19. doi: 10.3892/ijo.2017.4167.
    PubMed     Text format     Abstract available
    
    
    
70. KIM SL, Park YR, Lee ST, Kim SW, et al
    Parthenolide suppresses hypoxia-inducible factor-1alpha signaling and hypoxia induced epithelial-mesenchymal transition in colorectal cancer.
    Int J Oncol. 2017 Oct 18. doi: 10.3892/ijo.2017.4166.
    PubMed     Text format     Abstract available
    
    
    
71. LIU K, Li J, Wu X, Chen M, et al
    GSK-3beta inhibitor 6-bromo-indirubin-3'-oxime promotes both adhesive activity and drug resistance in colorectal cancer cells.
    Int J Oncol. 2017 Oct 16. doi: 10.3892/ijo.2017.4163.
    PubMed     Text format     Abstract available
    
    
    
72. JIANG D, Li J, Li J, Wang M, et al
    Combination of FGFR4 inhibitor Blu9931 and 5-fluorouracil effects on the biological characteristics of colorectal cancer cells.
    Int J Oncol. 2017 Oct 2. doi: 10.3892/ijo.2017.4143.
    PubMed     Text format     Abstract available
    
    
    
73. LEE YJ, Kang YR, Lee SY, Jin Y, et al
    Ginkgetin induces G2-phase arrest in HCT116 colon cancer cells through the modulation of bMyb and miRNA34a expression.
    Int J Oncol. 2017;51:1331-1342.
    PubMed     Text format     Abstract available
    
    
    September 2017
74. TEO WH, Chen HP, Huang JC, Chan YJ, et al
    Human cytomegalovirus infection enhances cell proliferation, migration and upregulation of EMT markers in colorectal cancer-derived stem cell-like cells.
    Int J Oncol. 2017 Sep 25. doi: 10.3892/ijo.2017.4135.
    PubMed     Text format     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Colorectal Neoplasms is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: